2018
DOI: 10.5812/ijpbs.63560
|View full text |Cite
|
Sign up to set email alerts
|

Motivational Interviewing Can Facilitate Entry to Matrix Treatment for Methamphetamine Dependence

Abstract: Background: Methamphetamine dependence on a stable methadone dose is a health problem in Iran (i.e. the most populated Persian Gulf country). However, many Iranian patients are not motivated to enter treatment. Objectives: The study aimed to assess the efficacy of motivational interviewing for entry to matrix treatment for methamphetamine dependence. Methods: A study was conducted on 275 Persian male and female methadone patients who were methamphetamine-dependent, however they reported unwillingness to receiv… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
16
0

Year Published

2019
2019
2020
2020

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 16 publications
(16 citation statements)
references
References 10 publications
0
16
0
Order By: Relevance
“…Participants reported poor motivation to change and received no substantial MA treatment. A study indicated that motivational interviewing is a beneficial strategy to encourage treatment entry and retention among women with MA use disorder [10]. Motivational interviewing needs to be provided for these women to increase motivation to change as part of continued MA treatment while undergoing methadone treatment.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Participants reported poor motivation to change and received no substantial MA treatment. A study indicated that motivational interviewing is a beneficial strategy to encourage treatment entry and retention among women with MA use disorder [10]. Motivational interviewing needs to be provided for these women to increase motivation to change as part of continued MA treatment while undergoing methadone treatment.…”
Section: Discussionmentioning
confidence: 99%
“…To date, few studies have been conducted on Iranian MA patients. Recent studies indicate that the high prevalence of MA use disorder remains a health problem among Iranian female methadone patients [10]. MA first appeared in 2005, when illegally imported from Southeast Asia, and recently, MA has been largely manufactured in the Persian context [1].…”
Section: Introductionmentioning
confidence: 99%
“…Furthermore, polysubstance use raises the risk of premature death due to overdose (14). Some domestic studies provided preliminary evidence for the effectiveness of behavioral interventions to treat amphetamine use during OMTs (15,16).…”
Section: Introductionmentioning
confidence: 99%
“…Nowadays, SUD has become a global problem and most countries in the world are involved with this problem (2). The prevalence and type of SUD varies between different countries and different jobs (3,4). About 7% of Americans over the age of 12 years have SUD (5).…”
Section: Introductionmentioning
confidence: 99%